ROCKWELL MEDICAL, INC.

RMTI

ROCKWELL MEDICAL, INC.

RMTI

Insider Sentiment (TTM):

Last Purchase:2025-04-11Last Sale:2026-01-02Shares Purchased (TTM):0Shares Sold (TTM):22,381

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:3,965,036Shares Outstanding:39,418,302Institutional Ownership Pct.:10.06%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	11	10	11	14	12	11	16	12	12	7	9	8
Available For Sale Securities Debt Securities Curr…	-	-	14	-	-	-	6	6	0	2	2	4
Debt Securities Available For Sale Excluding Accru…	14	14	-	10	6	6	-	-	-	-	-	-
Accounts Receivable Net Current	8	9	8	8	8	10	8	9	11	11	11	9
Inventory Net	3	3	3	4	4	5	6	6	6	6	6	5
Prepaid Expense And Other Assets Current	0	1	2	2	1	1	1	1	1	1	1	2
Assets Current	36	37	38	38	32	33	37	34	30	27	29	28
Property Plant And Equipment Net	5	4	5	5	5	5	6	6	6	6	6	7
Inventory Noncurrent	-	-	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	4	5	3	3	3	3	3	4	4	4	3	3
Finance Lease Right Of Use Asset	-	1	1	1	1	1	1	1	2	2	2	2
Intangible Assets Net Excluding Goodwill	9	10	10	10	10	10	10	10	10	11	11	11
Goodwill	1	1	1	1	1	1	1	1	1	1	1	1
Other Assets Noncurrent	1	1	1	1	1	1	1	1	1	1	1	1
Assets	57	57	57	57	53	54	59	57	53	51	52	53
Liabilities And Stockhold…
Accounts Payable Current	3	3	2	2	2	2	3	3	3	5	5	4
Accrued Liabilities Current	4	3	4	4	4	5	6	6	6	5	7	7
Asset Acquisition Contingent Consideration Liabili…	-	-	1	-	-	-	2	-	-	-	-	-
Business Combination Contingent Consideration Liab…	0	1	-	2	3	2	2	2	3	3	3	3
Operating Lease Liability Current	1	1	1	1	1	1	2	2	1	1	1	2
Finance Lease Liability Current	-	0	0	0	1	1	1	1	1	1	1	1
Contract With Customer Liability Current	-	-	0	0	0	0	0	0	0	0	0	0
Notes Payable	-	-	-	-	-	-	-	-	-	0	0	0
Long Term Debt Current	2	1	-	-	-	-	-	-	-	-	0	6
Short Term Bank Loans And Notes Payable	0	0	0	0	1	0	0	0	1	-	0	-
Contract With Customer Refund Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	11	10	10	10	11	11	14	14	15	15	17	21
Operating Lease Liability Noncurrent	3	3	1	2	2	1	2	2	2	3	1	2
Finance Lease Liability Noncurrent	-	0	0	0	1	1	1	1	1	1	2	2
Long Term Debt Noncurrent	7	8	9	9	9	9	8	8	8	8	8	3
Contract With Customer Liability Noncurrent	-	-	0	0	0	0	0	0	0	0	0	0
Business Combination Contingent Consideration Liab…	-	-	-	0	0	1	1	2	3	3	3	3
Other Liabilities Noncurrent	-	-	-	-	-	-	0	0	0	0	0	0
Asset Acquisition Contingent Consideration Liabili…	-	-	0	-	-	-	1	-	-	-	-	-
Liabilities	21	22	20	20	22	22	27	28	30	30	31	31
Stockholders Equity
Preferred Stock Value Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	441	440	440	439	431	431	430	426	422	420	418	417
Retained Earnings Accumulated Deficit	-406	-405	-403	-402	-401	-399	-398	-397	-399	-399	-397	-396
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	0	-0	0	-0	0
Stockholders Equity	35	36	37	37	30	32	33	29	23	21	21	22
Liabilities And Stockholders Equity	57	57	57	57	53	54	59	57	53	51	52	53
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	2	2	2	2	2	2	2	2	2	2	2	2
Allowance For Doubtful Accounts Receivable Current	-	-	-	-	-	-	0	-	-	-	0	-
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	170	170	170	170	170	170	170	170	170	170	170	170
Common Stock Shares Issued	4	4	4	4	3	3	3	3	3	3	3	3
Shares Outstanding	4	4	4	4	3	3	3	3	3	3	3	3

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-5.13%	-16.67%	-15.00%	-	-	-	-	-	-	-	-	-
2025	-1.92%	-21.15%	-7.69%	54.29%	16.19%	5.71%	3.12%	-10.42%	11.46%	-3.19%	-15.96%	-34.04%
2024	11.18%	1.18%	3.53%	33.64%	71.03%	75.23%	-24.73%	-17.67%	-27.92%	-24.29%	-20.00%	-27.14%
2023	-	-	-	-24.56%	-19.65%	-27.37%	-10.20%	-10.71%	-33.67%	5.26%	7.89%	24.34%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.25	3.74	3.98	3.92	2.89	2.95	2.63	2.41	2.00	1.79	1.73	1.32
Quick Ratio	2.96	3.32	3.46	3.34	2.42	2.41	2.12	1.92	1.52	1.32	1.31	0.99
Working Capital	25.19M	27.08M	28.58M	27.93M	20.66M	21.83M	22.94M	20.04M	14.86M	11.75M	12.13M	6.77M
Leverage & Debt
Debt to Equity	0.61	0.60	0.55	0.55	0.73	0.71	0.82	0.96	1.26	1.46	1.45	1.44
Interest Coverage TTM	-3.99	-4.26	-4.17	-4.27	-1.13	0.52	0.48	0.28	-1.42	-2.80	-2.90	-4.97
Debt Ratio	0.38	0.38	0.35	0.36	0.42	0.42	0.45	0.49	0.56	0.59	0.59	0.59
Efficiency & Turnover
Asset Turnover TTM	1.27	1.22	1.19	1.32	1.67	1.87	1.82	1.80	2.07	1.90	1.69	1.51
Days Sales Outstanding TTM	43.10	49.87	43.30	41.57	39.26	38.78	34.51	33.67	31.43	36.06	37.46	37.77
Receivables Turnover TTM	8.47	7.32	8.43	8.78	9.30	9.41	10.58	10.84	11.61	10.12	9.74	9.66
Per Share Metrics
Diluted EPS TTM	-1.28	-1.37	-1.48	-1.53	-0.61	-0.08	-0.15	-0.38	-1.49	-2.87	-3.62	-3.37
Free Cash Flow Per Share TTM	0.48	0.45	-0.33	-0.80	0.80	0.63	1.03	0.84	-1.79	-2.84	-4.16	-3.53
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	17.71%	17.07%	16.89%	15.15%	17.52%	17.87%	17.23%	16.91%	13.44%	10.59%	10.41%	10.11%
Operating Profit Margin TTM	-6.52%	-7.11%	-6.77%	-6.37%	-1.47%	0.59%	0.60%	0.59%	-3.28%	-7.58%	-7.98%	-10.00%
Net Profit Margin TTM	-7.33%	-7.98%	-7.67%	-7.30%	-2.39%	-0.27%	-0.47%	-1.25%	-5.06%	-9.72%	-10.09%	-11.49%
Growth Metrics
Net Revenue Growth (1Y)	-21.12%	-30.75%	-31.76%	-23.60%	-6.79%	12.82%	21.38%	22.37%	24.58%	13.45%	14.84%	17.44%
Net Income Growth (1Y)	142.21%	1,946.97%	1,007.08%	346.28%	-56.01%	-96.86%	-94.31%	-86.69%	-58.88%	-36.53%	-54.82%	-63.23%
EPS Growth (1Y)	109.94%	1,671.19%	855.81%	290.86%	-60.96%	-97.30%	-95.73%	-88.39%	-75.02%	-60.27%	-72.29%	-75.33%
Valuation Metrics
P/E TTM	-4.28	-6.49	-5.62	-7.84	-13.89	-145.99	-132.00	-101.34	-11.23	-5.78	-5.22	-6.16
P/B TTM	0.62	0.98	0.81	1.17	0.96	1.22	1.94	4.30	2.28	2.36	2.07	2.66
P/S TTM	0.31	0.52	0.43	0.57	0.33	0.39	0.62	1.27	0.57	0.56	0.53	0.71
Market Cap	21.77M	35.08M	29.86M	43.23M	29.16M	38.54M	63.36M	125.26M	53.59M	48.68M	44.08M	57.24M
Enterprise Value	20.26M	34.86M	28.44M	38.82M	25.95M	36.32M	56.77M	121.89M	50.60M	50.87M	43.95M	59.00M
Calculated Values
Free Cash Flow TTM	1.90M	1.76M	-1.20M	-2.87M	2.75M	2.16M	3.19M	2.64M	-5.44M	-8.34M	-9.70M	-9.72M
Net Debt	-1.52M	-227.00K	-1.42M	-4.41M	-3.21M	-2.22M	-6.59M	-3.37M	-2.99M	2.19M	-132.00K	1.75M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-01-02Sale

Owner: Hunter, Heather

Title: Chief Operating Officer

Shares: 2,868

Price/Share: $0.84

Value: $2,409.12

Shares Owned: 132,523

Relationship: Officer

Ownership: Direct

2026-01-02Sale

Owner: Neri, Jesse

Title: SVP and CFO

Shares: 886

Price/Share: $0.84

Value: $744.24

Shares Owned: 124,842

Relationship: Officer

Ownership: Direct

2025-11-18Sale

Owner: Cooper, John G

Title: -

Shares: 5,079

Price/Share: $0.87

Value: $4,418.73

Shares Owned: 140,372

Relationship: Director

Ownership: Direct

2025-10-01Sale

Owner: Neri, Jesse

Title: SVP and CFO

Shares: 886

Price/Share: $1.19

Value: $1,054.34

Shares Owned: 125,728

Relationship: Officer

Ownership: Direct

2025-10-01Sale

Owner: Strobeck, Mark

Title: President and CEO

Shares: 6,926

Price/Share: $1.19

Value: $8,241.94

Shares Owned: 330,826

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-01-02	Hunter, Heather	Officer	Chief Operating Officer	Direct	Sale	2,868	0.84	$2,409.12	132,523	4
2026-01-02	Neri, Jesse	Officer	SVP and CFO	Direct	Sale	886	0.84	$744.24	124,842	4
2025-11-18	Cooper, John G	Director	-	Direct	Sale	5,079	0.87	$4,418.73	140,372	4
2025-10-01	Neri, Jesse	Officer	SVP and CFO	Direct	Sale	886	1.19	$1,054.34	125,728	4
2025-10-01	Strobeck, Mark	Director,Officer	President and CEO	Direct	Sale	6,926	1.19	$8,241.94	330,826	4
2025-10-01	Chole, Timothy	Officer	SVP and CCO	Direct	Sale	2,868	1.19	$3,412.92	125,299	4
2025-10-01	Hunter, Heather	Officer	SVP, Chief Operating Officer	Direct	Sale	2,868	1.19	$3,412.92	135,391	4
2025-07-01	Neri, Jesse	Officer	SVP and CFO	Direct	Sale	886	0.82	$726.52	126,614	4/A
2025-07-01	Chole, Timothy	Officer	SVP and CCO	Direct	Sale	2,868	0.82	$2,351.76	128,167	4/A
2025-07-01	Strobeck, Mark	Director,Officer	President and CEO	Direct	Sale	6,926	0.82	$5,679.32	337,752	4/A
2025-04-11	Irrevocable, Larson Famil…	TenPercentOwner	-	Direct	Purchase	30,500	1.08	$32,940.00	3,557,500	4
2025-04-01	Chole, Timothy	Officer	SVP, Chief Commercial Officer	Direct	Sale	2,868	1.08	$3,097.44	46,035	4
2025-04-01	Neri, Jesse	Officer	SVP, FINANCE AND CFO	Direct	Sale	886	1.10	$974.60	30,000	4
2025-04-01	Strobeck, Mark	Director,Officer	President and CEO	Direct	Sale	6,926	1.08	$7,480.08	124,678	4
2025-01-02	Chole, Timothy	Officer	SVP, Chief Commercial Officer	Direct	Sale	1,001	2.05	$2,052.05	54,170	4
2025-01-02	Strobeck, Mark	Director,Officer	President and CEO	Direct	Sale	2,163	2.06	$4,455.78	145,038	4
2024-11-15	Ravich, Mark H	Director	-	Direct	Sale	10,000	2.40	$24,000.00	121,429	4
2024-10-01	Chole, Timothy	Officer	SVP, Chief Commercial Officer	Direct	Sale	1,001	3.69	$3,693.69	55,171	4
2024-10-01	Strobeck, Mark	Director,Officer	President and CEO	Direct	Sale	2,163	3.69	$7,981.47	147,201	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

10.06%

Inst. Shares: 3,965,036

Shares Outstanding: 39,418,302

2025-12-31

9.71%

Inst. Shares: 3,492,948

Shares Outstanding: 35,974,231

2025-09-30

8.83%

Inst. Shares: 3,179,235

Shares Outstanding: 36,024,940

2025-06-30

17.08%

Inst. Shares: 5,860,693

Shares Outstanding: 34,311,306

2025-03-31

20.27%

Inst. Shares: 6,914,793

Shares Outstanding: 34,107,640

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	3,965,036	39,418,302	10.06%
2025-12-31	3,492,948	35,974,231	9.71%
2025-09-30	3,179,235	36,024,940	8.83%
2025-06-30	5,860,693	34,311,306	17.08%
2025-03-31	6,914,793	34,107,640	20.27%
2024-12-31	8,139,530	31,058,539	26.21%
2024-09-30	9,296,799	31,551,805	29.47%
2024-06-30	5,743,823	30,451,622	18.86%
2024-03-31	5,086,269	29,327,204	17.34%
2023-12-31	4,663,198	23,322,915	19.99%
2023-09-30	4,969,768	27,521,088	18.06%
2023-06-30	2,589,373	18,496,640	14.00%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

ROCKWELL MEDICAL, INC. (RMTI) — SEC Financial Statements & Analysis

ROCKWELL MEDICAL, INC. (RMTI) is a pharmaceutical preparations company, incorporated in DE. ROCKWELL MEDICAL, INC. trades on Nasdaq as: RMTI. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), ROCKWELL MEDICAL, INC. reported a -21.12% year-over-year revenue growth, a Gross Profit Margin of 17.71% (TTM), a Debt-to-Equity ratio of 0.61x, a Price-to-Sales (P/S) ratio of 0.31x (TTM), a Price-to-Book (P/B) ratio of 0.62x (TTM), at a market cap of $21.77M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -21.12%
Gross Profit Margin TTM: 17.71%
Debt To Equity: 0.61x
P/S TTM: 0.31x
P/B TTM: 0.62x
Market Cap: $21.77M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ROCKWELL MEDICAL, INC. in?

ROCKWELL MEDICAL, INC. (RMTI) operates in the Pharmaceutical Preparations industry.

What is RMTI's market cap?

ROCKWELL MEDICAL, INC. (RMTI) has a market capitalization of $21.77M as of 2026-06-30.

What exchange does RMTI trade on?

ROCKWELL MEDICAL, INC. (RMTI) trades on the Nasdaq.

Where is ROCKWELL MEDICAL, INC. incorporated?

ROCKWELL MEDICAL, INC. is incorporated in DE.